This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human Nogo-A. Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis. Ozanezumab targets a protein called Neurite Outgrowth Inhibitor (NOGO-A) or Reticulon 4. NOGO-A is a protein that in humans is encoded by the RTN4 gene that has been identified as an inhibitor of neurite outgrowth specific to the central nervous system. NOGO-A is found at higher than normal levels in persons with MND.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-Human Nogo-A Recombinant Antibody (Ozanezumab)Recombinant humanized (from mouse) antibody expressed in CHO binding to human Nogo-A. Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis. Ozanezumab targets a protein called Neurite Outgrowth Inhibitor (NOGO-A) or Reticulon 4. NOGO-A is a protein that in humans is encoded by the RTN4 gene that has been identified as an inhibitor of neurite outgrowth specific to the central nervous system. NOGO-A is found at higher than normal levels in persons with MND.
DrugMonitor™ Anti-Ozanezumab Antibody (VS-1224-YC870)Ozanezumab has been utilized in clinical trials exploring the treatment of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Relapsing-Remitting Multiple Sclerosis. The DrugMonitor™ Anti-Ozanezumab Antibody (VS-1224-YC870) is an anti-drug antibody (ADA) against Ozanezumab. This drug-based antibody is raised in mice immunized with the Ozanezumab. The anti-Ozanezumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Ozanezumab in samples.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2437z | Mouse Anti-RTN4 Recombinant Antibody (clone 28B12) | WB, ELISA, IF, IP | Mouse IgM, κ |
HPAB-0294CQ | Mouse Anti-RTN4 Recombinant Antibody (clone mAb 3A6) | ELISA, WB | Mouse IgG1 |
HPAB-0295CQ | Human Anti-RTN4 Recombinant Antibody (clone h3A6) | ELISA, WB | Human IgG4 |
HPAB-0901-FY | Human Anti-RTN4 Recombinant Antibody (HPAB-0901-FY) | ELISA, Neut | Humanized IgG |
VS3-XY3491 | Rabbit Anti-RTN4 Recombinant Antibody (clone R05-4C9) | WB, IHC-P, ICC, IF, IP, FC | Rabbit IgG |
There are currently no Customer reviews or questions for AFC-TAB-903. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.